FNYS
PLXP

First New York Securities’s PLx Pharma Inc. Common Stock PLXP Stock Holding History

First New York Securities’s Portfolio PLXP Stock Details PLXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		$800 Sell
63
-187
-75% -$6.87K ﹤0.01% 82
2016
Q3 		$29K Sell
250
-38
-13% -$3.71K 0.02% 153
2016
Q2 		$22.8K Buy
288
+38
+15% +$3.29K 0.01% 120
2016
Q1 		$19K Buy
+250
New +$15.9K 0.01% 154

Other funds holding PLXP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
AIM
Acrospire Investment Management Chicago, Illinois $107M AUM 37.25% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
MC
Middleton & Co Boston, Massachusetts $942M AUM 19.03% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

First New York Securities's PLXP Position: Q4 2016 in Review

First New York Securities reduced its PLx Pharma Inc. Common Stock (PLXP) stake by 75% in Q4 2016, selling an estimated $6.87K and leaving 63 shares worth $800. The position accounts for ﹤0.01% of the portfolio, ranked #82.

First New York Securities first reported a position in PLXP in Q1 2016 and has held it in 4 quarters since. The position peaked at $29K in Q3 2016. 19 funds tracked by Wall St. Rank hold PLXP as of Q4 2016.

  • First New York Securities held 63 shares of PLx Pharma Inc. Common Stock worth $800 as of Q4 2016.
  • First New York Securities sold 187 PLx Pharma Inc. Common Stock shares in Q4 2016, an estimated $6.87K.
  • PLx Pharma Inc. Common Stock made up ﹤0.01% of First New York Securities's portfolio in Q4 2016, its #82 holding.
  • First New York Securities first reported a position in PLx Pharma Inc. Common Stock in Q1 2016 and has held it in 4 quarters since.
  • First New York Securities's PLx Pharma Inc. Common Stock position peaked at $29K in Q3 2016.
  • 19 funds tracked by Wall St. Rank held PLx Pharma Inc. Common Stock as of Q4 2016.

Based on First New York Securities's 13F filing for Q4 2016, filed 7 Feb 2017.